The landscape of dementia prognosis has evolved dramatically with the arrival of sophisticated biomarkers, which include amyloid PET scans, tau imaging, and blood-based exams which will detect Alzheimer's pathology years just before indications emerge. Whilst these technological improvements stand for outstanding progress in comprehension neurodege